Inrig Jula 4

What Happened

• Inrig Jula, Chief Medical Officer of Travere Therapeutics (TVTX), made a gift of 468 shares of company common stock. The filing shows the shares were disposed with a reported price of $0.00, so the reported cash proceeds are $0.
• This was a charitable disposition (gift), not a sale or purchase, and does not by itself indicate insider sentiment about the stock.

Key Details

• Transaction date: transfer occurred on June 22, 2026; gift authorization was given on June 16, 2026 (per footnote F1).
• Price/consideration: $0.00 per share; total reported proceeds $0 (transaction code G = Gift).
• Shares owned after transaction: not disclosed in the filing.
• Footnote: F1 states this was a bona fide gift of 468 shares to a donor-advised fund; authorization and transfer dates noted above.
• Filing timeliness: Reported on June 22, 2026 (no late filing indicated in the document).

Context

• Gifts to donor-advised funds or charities are commonly part of personal charitable or tax planning and should not be interpreted as a straightforward buy/sell signal about management’s view of the company.
• For retail investors, purchases and open-market buys tend to be more informative about insider sentiment than gifts or routine transfers.